4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000003
Chairperson & CEO sold 9,500 shares at an average $499.42 ($4,744,467)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
17 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $146.03 | $1,387,285 | 9,630 | D |
| 2026-03-03 | Sale : show line 2 in the form 10b5-1 | −283 | $491.68 | $139,146 | 9,347 | D |
| 2026-03-03 | Sale : show line 3 in the form 10b5-1 | −340 | $492.53 | $167,462 | 9,007 | D |
| 2026-03-03 | Sale : show line 4 in the form 10b5-1 | −456 | $493.71 | $225,132 | 8,551 | D |
| 2026-03-03 | Sale : show line 5 in the form 10b5-1 | −680 | $494.75 | $336,431 | 7,871 | D |
| 2026-03-03 | Sale : show line 6 in the form 10b5-1 | −555 | $495.87 | $275,209 | 7,316 | D |
| 2026-03-03 | Sale : show line 7 in the form 10b5-1 | −407 | $496.71 | $202,161 | 6,909 | D |
| 2026-03-03 | Sale : show line 8 in the form 10b5-1 | −1,075 | $498.01 | $535,362 | 5,834 | D |
| Open-market sales · 9,500 sh · avg $499.42 · $4,744,467 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 18 in the form 10b5-1 Stock Option | −9,500 | 221,000 | D |
Loading xslF345X05/primarydocument.xml…